title: Expression of myostatin, myostatin receptors and follistatin in diabetic rats submitted to exercise.
abstract: Myostatin (MSTN) has been implicated in metabolic adaptation to physiological stimuli, such as physical exercise, which is linked to improved glucose homeostasis. The aim of the present study was to evaluate the influence of exercise on the expression of MSTN, MSTN receptors (ActRIIB and ALK4) and follistatin (FS) in the muscle and fat of streptozotocin-induced diabetic rats. Control and diabetic rats were randomly assigned to a swimming training group (EC and ED, respectively) and a sedentary group (SC and SD, respectively). Exercising animals swam for 45 min at 0900 and 1700 hours, 5 day/week, for 4 weeks. The mRNA expression of MSTN, ActRIIB, ALK4 and FS mRNA was quantified by real-time reverse transcription-polymerase chain reaction. Expression of MSTN and FS mRNA increased in the muscle and subcutaneous fat of SD compared with SC rats. Expression of ActRIIB mRNA was increased in the muscle, mesenteric fat and brown adipose tissue (BAT) of SD compared with SC rats, whereas ALK4 mRNA expression was only increased in the BAT of SD compared with SC rats. After training, MSTN and ActRIIB expression was lower in the BAT of EC compared with SC rats. Expression of MSTN mRNA increased in the mesenteric fat of ED compared with SD rats, whereas FS mRNA expression decreased in the muscle, mesenteric and subcutaneous fat and BAT. Lower ALK4 mRNA expression was noted in the BAT of ED compared with SD rats. These results indicate that MSTN, its receptors and FS expression change in both the muscle and fat of diabetic rats and that the expression of these factors can be modulated by exercise in diabetes.
authors.affiliation: Department of Physical Therapy, Federal University of São Carlos, São Carlos, Brazil.
authors.forename: Daniela B
authors.initials: DB
authors.lastname: Dutra
authors.forename: Patrícia G
authors.initials: PG
authors.lastname: Bueno
authors.forename: Rafaella N
authors.initials: RN
authors.lastname: Silva
authors.forename: Natália H
authors.initials: NH
authors.lastname: Nakahara
authors.forename: Heloísa S
authors.initials: HS
authors.lastname: Selistre-Araújo
authors.forename: Keico O
authors.initials: KO
authors.lastname: Nonaka
authors.forename: Angela Mo
authors.initials: AM
authors.lastname: Leal
mesh_terms: D030201:Activin Receptors, Type I / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D002001:Adipose Tissue, Brown / Q000378:metabolism; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D038681:Follistatin / Q000096:biosynthesis* / Q000235:genetics; D005786:Gene Expression Regulation; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism; D055435:Myostatin / Q000096:biosynthesis* / Q000235:genetics; D010805:Physical Conditioning, Animal / Q000502:physiology*; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar
chemical_list: C577879:Acvr1B protein, rat; D038681:Follistatin; D055435:Myostatin; D012333:RNA, Messenger; D030201:Activin Receptors, Type I